glp 1 藥物 有 哪些 💊 💊💊 减肥药大比拼！🔥🔥🔥 Tirzepatide vs Semaglutide 谁更强？谁副作用更少？谁瘦得更快？⚖️ 这两种“神药 ”都曾登上热搜，都是GLP-1类药物，但机制、效果、副作用不完全一样！ 📌 Semaglutide（Ozempic / Wegovy）是早期明星 糖尿病患者，GLP-1 受體促效劑（GLP-1RA）與SGLT2 抑制劑（SGLT2i）都有 保護心血管效果：主治項目：甲狀腺疾病、糖尿病、高血壓、高血脂、慢性腎臟病、內分泌失調、骨質疏鬆、疫苗接種-游新診所/喜恩診所(台南內分泌新陳代謝科)

Science diagram

Clin Auton.Res 2000;10(1):13-16

Patients with indicators of high-risk or established ASCVD, chronic kidney disease, or heart failure According to the ADA, when considering an agent for add-on to metformin background therapy, the first recommended consideration is whether or not the patient has indicators of high-risk or established ASCVD, chronic kidney disease (CKD), or heart failure ( Figure 2 )

Patients taking semaglutide injection should maintain consistent hydrationtypically 2.53.5 liters of water dailybecause both semaglutide and creatine require adequate fluid for optimal function

189 The barrier function constitutes the fundamental role of ECs